The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The prevalence of psychotic symptoms among methamphetamine users
Abstract
Aims To examine the prevalence of psychotic symptoms among regular methamphetamine users. Design Cross‐sectional survey. Setting Participants were recruited from Sydney, Australia, through advertisements in free‐press magazines, flyers and through word‐of‐mouth. Participants Methamphetamine users (n = 309) who were aged 16 years or over and took the drug at least monthly during the past year. Measurements A structured face‐to‐face interview was used to assess drug use, demographics and symptoms of psychosis in the past year. Measures of psychosis included: (a) a psychosis screening instrument derived from the Composite International Diagnostic Interview; and (b) the Brief Psychiatric Rating Scale subscales of suspiciousness, unusual thought content, and hallucinations. Dependence on methamphetamine was measured using the Severity of Dependence Scale. Findings Thirteen per cent of participants screened positive for psychosis, and 23% had experienced a clinically significant symptom of suspiciousness, unusual thought content or hallucinations in the past year. Dependent methamphetamine users were three times more likely to have experienced psychotic symptoms than their non‐dependent counterparts, even after adjusting for history of schizophrenia and other psychotic disorders. Conclusion The prevalence of psychosis among the current sample of methamphetamine users was 11 times higher than among the general population in Australia. Dependent methamphetamine users are a particularly high‐risk group for psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
GOSSOP, M., DARKE, S., GRIFFITHS, P., HANDO, J., POWIS, B., HALL, W., & STRANG, J. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.9056072.x · Cited by 1,343
Andrews, G., Henderson, S., & Hall, W. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.145 · Cited by 933
Training and quality assurance with the Brief Psychiatric Rating Scale: "The drift busters."
Ventura, J., Green, M. F., Shaner, A. L., & Liberman, R. P. (1993) · International Journal of Methods in Psychiatric Research · Cited by 748
Stimulants : neurochemical, behavioral, and clinical perspectives
Creese, I. (1983) · Raven Press eBooks · Cited by 698
Connell, P. H. (1957) · BMJ · doi:10.1136/bmj.1.5018.582 · Cited by 450
Amphetamine psychosis: Behavioral and biochemical aspects
Angrist, B., Sathananthan, G., Wilk, S., & Gershon, S. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90064-8 · Cited by 326
Stimulant psychosis: systematic review
Curran, C., Byrappa, N., & McBride, A. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.3.196 · Cited by 318
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008353 · Cited by 295
Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users
Topp, L., & Mattick, R. P. (1997) · Addiction · doi:10.1046/j.1360-0443.1997.9278397.x · Cited by 242
DEGENHARDT, L., & HALL, W. (2001) · Psychological Medicine · doi:10.1017/s0033291701003865 · Cited by 193
Psychosis and drug dependence: results from a national survey of prisoners
Farrell, M., Boys, A., Bebbington, P., Brugha, T. S., Coid, J. W., Jenkins, R., Lewis, G., Meltzer, H., Marsden, J., Singleton, N., et al. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.5.393 · Cited by 156
Stimulant Psychosis: Symptom Profile and Acute Clinical Course
Harris, D. S., & Batki, S. L. (2000) · American Journal on Addictions · doi:10.1080/10550490050172209 · Cited by 154
Assault and Homicide Associated with Amphetamine Abuse
Ellinwood, E. H. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.9.1170 · Cited by 152
Psychological morbidity and route of administration among amphetamine users in Sydney, Australia
Hall, W., Hando, J., Darke, S. G., & Ross, J. E. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.9118110.x · Cited by 147
Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan
Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., Horita, N., & Kaneko, T. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01541.x · Cited by 135
Farrell, M., Marsden, J., Ali, R. L., & Ling, W. W. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00195.x · Cited by 116
Dalmau, A., Bergman, B., & Brismar, B. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)00234-5 · Cited by 61
Is cannabis use psychotogenic?
Hall, W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68012-4 · Cited by 54
Half a million Americans use methamphetamine every week
Roehr, B. (2005) · BMJ · doi:10.1136/bmj.331.7515.476 · Cited by 43
Drug policy for methamphetamine use urgently needed.
Parry, C. D. H., MYERS, B. J., & Plüddemann, A. (2004) · PubMed · Cited by 38
Use of brief screening instrument for psychosis: results of a ROC analysis
Degenhardt, L. J., Hall, W., Korten, A., & Jablensky, A. V. (2005) · Cited by 23
Amphetamine Abuse and Violence
Asnis, S. F., Smith, R. C., & Crim, D. (1978) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1978.10471541 · Cited by 23
Cited by
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
A review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
Major physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675
Self-citationNeurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 671
The Methamphetamine Problem in the United States
Gonzales, R., Mooney, L., & Rawson, R. A. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103600 · Cited by 361
Metadata
- Authors
- McKetin, R., McLaren, J., Lubman, D. I., & Hides, L.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2006-09
- Volume
- 101
- Issue
- 10
- Pages
- 1473-1478
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2056425055
- Cited by
- 393
- References
- 23
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.